Mitsubishi Ufj Kokusai Asset Management Co., Ltd. Horizon Therapeutics Public LTD CO Transaction History

Mitsubishi Ufj Kokusai Asset Management Co., Ltd.

$71.7 Billion
Q1 2024

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 07, 2023	BUY	$98.98 - $115.74 $587,842 - $687,379	5,939 Added 7.02%	90,598 $10.5 Million
Q2 2023 Aug 09, 2023	BUY	$96.34 - $112.38 $989,315 - $1.15 Million	10,269 Added 13.8%	84,659 $8.71 Million
Q1 2023 May 08, 2023	BUY	$107.32 - $113.5 $405,991 - $429,370	3,783 Added 5.36%	74,390 $8.12 Million
Q4 2022 Feb 07, 2023	SELL	$62.39 - $113.8 $1.17 Million - $2.14 Million	-18,789 Reduced 21.02%	70,607 $8.04 Million
Q3 2022 Nov 01, 2022	SELL	$58.92 - $84.67 $4.68 Million - $6.73 Million	-79,494 Reduced 47.07%	89,396 $5.53 Million

Q2 2022 Aug 04, 2022	BUY	$79.4 - $116.36 $921,119 - $1.35 Million	11,601 Added 7.38%	168,890 $13.5 Million
Q1 2022 May 09, 2022	BUY	$86.42 - $109.81 $1.13 Million - $1.44 Million	13,112 Added 9.09%	157,289 $16.5 Million
Q4 2021 Feb 07, 2022	BUY	$98.56 - $119.91 $1.19 Million - $1.45 Million	12,058 Added 9.13%	144,177 $15.6 Million
Q3 2021 Nov 04, 2021	BUY	$91.91 - $110.37 $213,415 - $256,279	2,322 Added 1.79%	132,119 $14.5 Million
Q2 2021 Aug 06, 2021	BUY	$86.24 - $95.92 $7.22 Million - $8.03 Million	83,711 Added 181.64%	129,797 $12.2 Million
Q1 2021 May 06, 2021	BUY	$71.83 - $95.48 $309,156 - $410,945	4,304 Added 10.3%	46,086 $4.24 Million
Q4 2020 Feb 09, 2021	BUY	$67.0 - $84.39 $2.8 Million - $3.53 Million	41,782 New	41,782 $3.06 Million

Others Institutions Holding HZNP

# of Institutions

Shares Held

2.07M

Call Options Held

Put Options Held

20K

View Full List

About Horizon Therapeutics Public Ltd Co

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

More about HZNP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mitsubishi Ufj Kokusai Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mitsubishi Ufj Kokusai Asset Management Co., Ltd. with notifications on news.

Account